|Grant, 8/2011 ||$25k|
|Grant, 3/2013 |
Nanotechnology Institute in Philadelphia Pennsylvania
Eqalix, Inc. is an emerging regenerative medicine development company with a goal of enhancing the quality of life of consumers and patients by providing novel nano-materials for the repair and regeneration of diseased, traumatized, and aging tissues. Our innovative technologies are intended to revolutionize the unmet needs in multiple commercial and therapeutic applications in the regenerative medicine space. The global market for tissue engineering and regeneration products will grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%, powered by increasing focus on stem cell research, greater usage of non-autograft products, ageing baby boomers and higher investments in R&D activity.